drugset / Trial / NCT00272896

Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

NCT00272896

Completed 12 enrolled Danish Headache Center
RandomizedCrossoverDouble-blindDiagnostic

Summary

We hypothesized that infusion of VIP may induce headache/migraine in migraineurs and that VIP-induced headache may be associated with dilation of intra- and extracranial vessels. To test this hypothesis, we performed a double blind placebo-controlled crossover study in migraineurs and studied the effect on headache and cerebral and systemic hemodynamic parameters.

Timeline

Start
2004-10
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasoactive Intestinal Peptide Peptide Intravenous

Indications